Murine Model for Measuring Effects of Humanized-Dosing of Antibiotics on the Gut Microbiome

There is a current need for enhancing our insight in the effects of antimicrobial treatment on the composition of human microbiota. Also, the spontaneous restoration of the microbiota after antimicrobial treatment requires better understanding. This is best addressed in well-defined animal models. We here present a model in which immune-competent or neutropenic mice were administered piperacillin-tazobactam (TZP) according to human treatment schedules. Before, during and after the TZP treatment, fecal specimens were longitudinally collected at established intervals over several weeks. Gut microbial taxonomic distribution and abundance were assessed through culture and molecular means during all periods. Non-targeted metabolomics analyses of stool samples using Quadrupole Time of Flight mass spectrometry (QTOF MS) were also applied to determine if a metabolic fingerprint correlated with antibiotic use, immune status, and microbial abundance. TZP treatment led to a 5–10-fold decrease in bacterial fecal viability counts which were not fully restored during post-antibiotic follow up. Two distinct, relatively uniform and reproducible restoration scenarios of microbiota changes were seen in post TZP-treatment mice. Post-antibiotic flora could consist of predominantly Firmicutes or, alternatively, a more diverse mix of taxa. In general, the pre-treatment microbial communities were not fully restored within the screening periods applied. A new species, closely related to Eubacterium siraeum, Mageeibacillus indolicus, and Saccharofermentans acetigenes, became predominant post-treatment in a significant proportion of mice, identified by 16S rRNA gene sequencing. Principal component analysis of QTOF MS of mouse feces successfully distinguished treated from non-treated mice as well as immunocompetent from neutropenic mice. We observe dynamic but distinct and reproducible responses in the mouse gut microbiota during and after TZP treatment and propose the current murine model as a useful tool for defining the more general post-antibiotic effects in the gastro-intestinal ecosystem where humanized antibiotic dosing may ultimately facilitate extrapolation to humans.

[1]  R. Knight,et al.  Evaluating Organism-Wide Changes in the Metabolome and Microbiome following a Single Dose of Antibiotic , 2020, mSystems.

[2]  D. Nicolau,et al.  Human-Simulated Antimicrobial Regimens in Animal Models: Transparency and Validation Are Imperative , 2020, Antimicrobial Agents and Chemotherapy.

[3]  J. García-Ojalvo,et al.  Antithetic population response to antibiotics in a polybacterial community , 2020, Science Advances.

[4]  Benjamin H. Good,et al.  Longitudinal linked-read sequencing reveals ecological and evolutionary responses of a human gut microbiome during antibiotic treatment , 2019, bioRxiv.

[5]  M. Gerstein,et al.  Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis , 2019, Nature Communications.

[6]  E. Lefkowitz,et al.  Individualized recovery of gut microbial strains post antibiotics , 2019, npj Biofilms and Microbiomes.

[7]  Hu Li,et al.  Microbial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut Microbiome. , 2019, Cell metabolism.

[8]  H. Quezada,et al.  The race between drug introduction and appearance of microbial resistance. Current balance and alternative approaches. , 2019, Current opinion in pharmacology.

[9]  M. Willmann,et al.  Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study , 2019, BMC Biology.

[10]  P. Mucha,et al.  Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections. , 2019, The Journal of clinical investigation.

[11]  A. Andremont,et al.  Impact of Antibiotic Gut Exposure on the Temporal Changes in Microbiome Diversity , 2019, Antimicrobial Agents and Chemotherapy.

[12]  H. Blix,et al.  Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  S. Keely,et al.  Microbiome-focused asthma management strategies. , 2019, Current opinion in pharmacology.

[14]  Tomoyoshi Soga,et al.  Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer , 2019, Nature Medicine.

[15]  S. Morjaria,et al.  Antibiotic-Induced Shifts in Fecal Microbiota Density and Composition during Hematopoietic Stem Cell Transplantation , 2019, Infection and Immunity.

[16]  Jeremy J. Barr,et al.  Phage Therapy in the Postantibiotic Era , 2019, Clinical Microbiology Reviews.

[17]  Jian Ye,et al.  Reply to the paper: Misunderstood parameters of NCBI BLAST impacts the correctness of bioinformatics workflows , 2018, Bioinform..

[18]  W. D. de Vos,et al.  Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans , 2018, The Journal of antimicrobial chemotherapy.

[19]  Yi Guan,et al.  Two Methods for Mapping and Visualizing Associated Data on Phylogeny Using Ggtree. , 2018, Molecular biology and evolution.

[20]  Paul Theodor Pyl,et al.  Recovery of gut microbiota of healthy adults following antibiotic exposure , 2018, Nature Microbiology.

[21]  J. Sambrook,et al.  Quantification of RNA by Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR). , 2018, Cold Spring Harbor protocols.

[22]  P. Lawson,et al.  Petroclostridium xylanilyticum gen. nov., sp. nov., a xylan-degrading bacterium isolated from an oilfield, and reclassification of clostridial cluster III members into four novel genera in a new Hungateiclostridiaceae fam. nov. , 2018, International journal of systematic and evolutionary microbiology.

[23]  D. Rasko,et al.  Responses of the Human Gut Escherichia coli Population to Pathogen and Antibiotic Disturbances , 2018, mSystems.

[24]  J. Nielandt,et al.  Disbiome database: linking the microbiome to disease , 2018, BMC Microbiology.

[25]  G. Weinstock,et al.  Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli , 2018, mBio.

[26]  Rob Knight,et al.  Current understanding of the human microbiome , 2018, Nature Medicine.

[27]  Peer Bork,et al.  Extensive impact of non-antibiotic drugs on human gut bacteria , 2018, Nature.

[28]  S. Janga,et al.  Transcriptome analysis of developing lens reveals abundance of novel transcripts and extensive splicing alterations , 2017, Scientific Reports.

[29]  E. Tacconelli,et al.  Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone , 2017, Antimicrobial Agents and Chemotherapy.

[30]  E. Le Chatelier,et al.  Protection of the Human Gut Microbiome From Antibiotics , 2017, bioRxiv.

[31]  D. Scott,et al.  The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors , 2017, Current Gastroenterology Reports.

[32]  S. Morjaria,et al.  Commensal microbes provide first line defense against Listeria monocytogenes infection , 2017, The Journal of experimental medicine.

[33]  G. Gerber,et al.  Antibiotic effects on gut microbiota and metabolism are host dependent. , 2016, The Journal of clinical investigation.

[34]  Jan P. Meier-Kolthoff,et al.  Correction: Corrigendum: The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota , 2016, Nature Microbiology.

[35]  F. Raymond,et al.  Partial recovery of microbiomes after antibiotic treatment , 2016, Gut microbes.

[36]  T. R. Licht,et al.  Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class , 2015, PloS one.

[37]  F. Raymond,et al.  The initial state of the human gut microbiome determines its reshaping by antibiotics , 2015, The ISME Journal.

[38]  A. Weintraub,et al.  Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota. , 2015, International journal of antimicrobial agents.

[39]  Nicholas A. Bokulich,et al.  Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment , 2015, Nature Communications.

[40]  Martina Sassone-Corsi,et al.  No Vacancy: How Beneficial Microbes Cooperate with Immunity To Provide Colonization Resistance to Pathogens , 2015, The Journal of Immunology.

[41]  S. Hillier,et al.  Mageeibacillus indolicus gen. nov., sp. nov.: a novel bacterium isolated from the female genital tract. , 2015, Anaerobe.

[42]  Bernard M. Corfe,et al.  Dysbiosis of the gut microbiota in disease , 2015, Microbial ecology in health and disease.

[43]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[44]  Alison S. Waller,et al.  Individuality and temporal stability of the human gut microbiome , 2014, Central Asian journal of global health.

[45]  Bo Li,et al.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection , 2014, Nature Communications.

[46]  E. Choi,et al.  The impact of the increased use of piperacillin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[47]  Alison S. Waller,et al.  Genomic variation landscape of the human gut microbiome , 2012, Nature.

[48]  Christina A. Sutherland,et al.  In Vivo Comparison of CXA-101 (FR264205) with and without Tazobactam versus Piperacillin-Tazobactam Using Human Simulated Exposures against Phenotypically Diverse Gram-Negative Organisms , 2011, Antimicrobial Agents and Chemotherapy.

[49]  S. Salzberg,et al.  FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..

[50]  J. Burgess,et al.  Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. , 2011, Journal of microbiological methods.

[51]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[52]  N. Socci,et al.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. , 2010, The Journal of clinical investigation.

[53]  D. Relman,et al.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation , 2010, Proceedings of the National Academy of Sciences.

[54]  Irina Dana Ofiteru,et al.  Combined niche and neutral effects in a microbial wastewater treatment community , 2010, Proceedings of the National Academy of Sciences.

[55]  D. Nicolau,et al.  In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae , 2010, Antimicrobial Agents and Chemotherapy.

[56]  Anders F. Andersson,et al.  Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome , 2010, PloS one.

[57]  O. Gascuel,et al.  SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. , 2010, Molecular biology and evolution.

[58]  Ning Ma,et al.  BLAST+: architecture and applications , 2009, BMC Bioinformatics.

[59]  Rob Knight,et al.  PyNAST: a flexible tool for aligning sequences to a template alignment , 2009, Bioinform..

[60]  Adam P. Arkin,et al.  FastTree: Computing Large Minimum Evolution Trees with Profiles instead of a Distance Matrix , 2009, Molecular biology and evolution.

[61]  Les Dethlefsen,et al.  The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.

[62]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[63]  Hagit Shatkay,et al.  BNTagger: improved tagging SNP selection using Bayesian networks , 2006, ISMB.

[64]  D. Xuan,et al.  Pharmacokinetic and Pharmacodynamic Evaluation of Two Dosing Regimens for Piperacillin‐Tazobactam , 2002, Pharmacotherapy.

[65]  H. Vlamakis,et al.  Evidence for Extensive Resistance Gene Transfer amongBacteroides spp. and among Bacteroides and Other Genera in the Human Colon , 2001, Applied and Environmental Microbiology.

[66]  V. Albert,et al.  Studying Evolutionary Dynamics of Gene Families Encoding SUMO-Activating Enzymes with SeaView and ProtTest. , 2016, Methods in molecular biology.

[67]  Neil Hunter,et al.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.